Skip to the content.

October 23, 2022 Analysis of EU national data

This is an update to the analysis approach first used for the July 2022 analyses of European data. See the descriptions from those pages for background about the analysis. The method uses hospital admission data alone to estimate population-level immunity by the shape of the BA.2 wave.

Model fits to data: waning of immunity is clearly established

The ECDC hospital admission data repository has stale data, so the OWID repository has been used to supplement the ECDC data.

With this most recent data, projections show the next peak to come earlier and have lower magnitude than last week’s projections, except for Switzerland. The future trajectory depends on the rate of waning, and the approach that worked well at the beginning of the waning phase (3 parameters: fraction, delay time mean, and delay time standard deviation) may not be sufficient to describe data well. The fit to UK data for past few weeks is poor.

Belgium

be

France

fr

Ireland

ie

Norway

no

Switzerland

ch

United Kingdom

gb

waning parameter fit results

The model for Ireland was not adjusted this week: it is the same as fitted for the October 9 analysis.

Country a_5 escape frac wane frac wane delay wane sigma
Belgium 2.8 0.055 0.101 254.8 6.6
France 2.1 0.1 0.218 244.8 16.7
Ireland 1.5 0.028 0.51 161.9 21.2
Norway 2.5 0.0 0.357 275.8 24.1
Switzerland 3.0 0.031 0.537 303.5 116.3
United Kingdom 2.4 0.03 0.464 252.9 62.2

comparison of waning and infection rates

The figure below shows the daily waning and infection rates (as fractions of the entire populations). The resurgance of BA.5 is due to waning immunity, and once new infection rates exceed waning rates, the growth rate becomes negative again.

eu

return to case studies